Price to Sales ratio Analysis of Onconova Therapeutics Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY PS
Period Ending - Dec-23
Very Poor PS
92434581
Period Ending - Dec-22
Very Poor PS
92.08
Growth
100385527 %
Trailing Twelve Months PS
Period Ending - Dec-23
Very Poor PS
93.56
PS Analysis of Onconova Therapeutics Inc
| P/S Ratio of Onconova Therapeutics Inc with value of 93.56 indicates that stock price is high compared to sales of the company and may be overvalued. |
| PS Ratio of ONTX rose handsomely by 100385527 % this year. |
| PS Ratio of ONTX trending up for at least three Years. |
| PS Ratio with value of 0.0291 was lowest in Year Dec-19 in last Five Years. |
| Latest PS Ratio with value of 92434581 is Greater than Average PS of 18486950 in last five years. |
Other PS Related Info of ONTX that may interest you.
Onconova Therapeutics Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| ONTX | 0.9953 | 1.0 | 0.470 % | Biotechnology |
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions. more ..
PS Related Ratios
| PriceToBookRatio | PriceToEarningRatio | AssetTurnoverRatio |
Tsr Value Index
| Very Low Value Stock | |
FY - Historical Price to Sales of Onconova Therapeutics Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| PS | 92434581 | 92.08 | 74.13 | 3.33 | 0.0291 | 0.0149 | 0.0002 |
| Change | 100385527 % | 24.22 % | 2124.26 % | 11333.70 % | 96.21 % | 6507.44 % | 1332.79 % |
FY Chart of Price to Sales of Onconova Therapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)